Pablo Ernesto Pérez

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

A Lecharpentier, Philippe Vielh, Pablo Ernesto Pérez et al. · British Journal of Cancer · 2011 · 373 citations · Full text

Medicine, Oncology, Pathology +17

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)

Fabrice Barlési, Arnaud Scherpereel, Achim Rittmeyer et al. · Journal of Clinical Oncology · 2013 · 327 citations

Medicine, Oncology, Pharmacology +12

First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer

Keunchil Park, Chong‐Jen Yu, Sang-We Kim et al. · JAMA Oncology · 2015 · 230 citations

Medicine, Oncology, Pharmacology +13

Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma

Aysegül Ilhan‐Mutlu, Matthias Osswald, Yunxiang Liao et al. · Molecular Cancer Therapeutics · 2016 · 122 citations · Full text

Medicine, Oncology, Pharmacology +17

CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells

Eduardo Silva-Pavez, Paulina Villar, César Trigo et al. · Cell Death and Disease · 2019 · 62 citations · Full text

Life Sciences, Oncology, Pharmacology +17